Parsonage v. Wal-Mart Associates - Employment Law

The California Court of Appeal has issued an opinion in the case of Parsonage v. Wal-Mart Associates. This appellate decision addresses employment law issues, potentially impacting how wage and hour disputes are handled in California.

Esparza v. Super Ct. - Case Details

This document provides case details for Esparza v. Super Ct. The filing is from the California Courts and is dated February 5, 2026. It pertains to a specific court case and does not introduce new regulations or enforcement actions.

Bartholomew v. Parking Concepts, Inc. - Published Opinion

The California Court of Appeal published an opinion in Bartholomew v. Parking Concepts, Inc. This decision addresses legal principles relevant to employment and civil procedure within the state. The publication provides clarity on specific legal interpretations for employers and legal professionals.

FINRA Interpretive Letters on Rule Application

FINRA has published interpretive letters providing guidance on the application of specific FINRA rules under various circumstances. These letters clarify staff views on rules related to communications with the public, account transfers, and registration categories.

FINRA FAQs on Compliance, Advertising, AML, and Trade Reporting

FINRA has published a collection of Frequently Asked Questions (FAQs) covering various compliance topics, including customer assistance in investigations, 529 Savings Plans, accounts at other broker-dealers, advertising, alternative display facilities, anti-money laundering, arbitration, blue sheets, books and records, breakpoints, broker-dealer registration, recruitment disclosures, BrokerCheck, business continuity planning, and CRD.

FINRA Exemptive Letters List

FINRA has published a list of its exemptive letters, including those related to TRACE ATS Reporting, Municipal Securities, and Initial Public Offerings (IPOs). These letters provide guidance to industry professionals on FINRA's decision-making rationale for specific situations.

FINRA Proposes New Trade Reporting Facility Fees Rule

FINRA has proposed a new rule, FINRA Rule 7660B, to establish fees for FINRA members who do not use the FINRA/NYSE Trade Reporting Facility but purchase specified services. This proposal is open for public comment.

FINRA proposes rule changes for underwriting and private placements

FINRA has proposed rule changes to amend Rules 5110 and 5123 concerning underwriting terms and private placements. The proposed changes aim to clarify valuation methods for underwriting compensation, introduce new exemptions, and expand existing exemptions for certain investors.

FINRA Proposes New Outside Activities Rule, Deletes Old Ones

FINRA has filed a proposed rule change with the SEC to adopt a new Rule 3290 concerning outside activities requirements for registered persons and to delete existing Rules 3270 and 3280. The proposed changes aim to enhance member review of activities with heightened risks while reducing unnecessary burdens.

FINRA Proposes Intraday Margin Standards Replacing Day Trading Rules

FINRA has proposed a rule change to replace its current day trading margin provisions with intraday margin standards. This proposal, SR-FINRA-2025-017, would amend FINRA Rule 4210 and eliminate existing day trading margin requirements. The SEC is currently reviewing the proposal.

FINRA proposes rule change on bona fide market making exception

FINRA has proposed a rule change (SR-FINRA-2025-016) to amend FINRA Rule 6830 concerning data reporting under the Consolidated Audit Trail (CAT). The change aims to align reporting requirements with amendments to the CAT NMS Plan regarding the bona fide market making exception under SEC Regulation SHO.

FINRA Amends Annual Reports Extension Policy

FINRA has amended its Annual Reports Extension of Time Request Policy, updating the information required from firms and their auditors. The updated policy, effective December 29, 2025, streamlines the extension process by modifying auditor representation requirements and shifting certain representations to the firm's Principal Financial Officer.

FINRA Final Statements for Broker-Dealers and Investment Advisers

FINRA has made Final Statements available for broker-dealers and investment adviser firms regarding renewal fees for 2026. Firms must review their statements, reconcile any discrepancies, and remit additional payments by January 23, 2026.

FINRA Seeks Comment on Rule Revisions for Investor Protection

FINRA is seeking public comment on proposed rule revisions aimed at enhancing member firms' ability to protect senior investors from financial exploitation and all investors from fraud. The proposed amendments focus on customer account information and temporary delays for suspected fraud, with a comment deadline of March 9, 2026.

FINRA Trade Reporting Enhancements for Fractional Share Transactions

FINRA is reminding firms of upcoming trade reporting enhancements for fractional share transactions, effective February 23, 2026. Members will be required to report fractional share quantities up to six digits after the decimal in a new field.

FINRA Guidance on Negative Consent for Bulk Customer Account Transfers

FINRA has issued guidance to reduce burdens for broker-dealers regarding the use of negative consent for bulk customer account transfers. This notice eliminates the requirement for firms to submit draft letters to FINRA for review and approval, consolidating existing guidance and providing effective practices.

ICO Guidance on Subject Access Requests

The UK Information Commissioner's Office (ICO) has published guidance on subject access requests (SARs) under GDPR. The guidance is aimed at large businesses in the public, private, and third sectors, with resources also available for small businesses.

ICO Guidance on Individual Rights and GDPR

The UK's Information Commissioner's Office (ICO) has updated its guidance on individual rights under GDPR. This update is in anticipation of the Data (Use and Access) Act 2025 and indicates that further changes may occur. The guidance is primarily aimed at large businesses.

ICO Guidance on Lawful Basis for Personal Data Processing

The UK's Information Commissioner's Office (ICO) has updated its guidance on the lawful basis for processing personal data. This guidance is under review due to upcoming legislation, the Data (Use and Access) Act 2025, and may be subject to change.

UK GDPR: Controllers and Processors Definitions and Responsibilities

The UK's Information Commissioner's Office (ICO) has updated its guidance on definitions and responsibilities for data controllers and processors under UK GDPR. This update is in anticipation of the Data (Use and Access) Act 2025 and is suitable for large businesses, with resources also available for small businesses.

ICO Guidance on UK GDPR International Data Transfers

The UK's Information Commissioner's Office (ICO) has published updated guidance on international transfers of personal data under UK GDPR. The guidance consolidates information on adequacy regulations, appropriate safeguards, transfer risk assessments, and exceptions for restricted transfers.

MHRA Medical Devices Exceptional Use Authorisations List Updated

The UK's MHRA has updated its list of medical devices granted exceptional use authorisations. This guidance document provides transparency on manufacturers and devices that have received exemptions, including those whose authorisations have expired or been cancelled.

MHRA: Stop using non-sterile alcohol-free wipes due to infection risk

The MHRA and UKHSA are advising the public not to use four specific non-sterile alcohol-free wipe products due to contamination with Burkholderia stabilis bacteria. These products have been withdrawn from sale, but may still be in homes, and are linked to 59 cases, including one death.

MHRA: Quetiapine Oral Suspension Recalled Due to Incorrect Active Ingredient

The MHRA has issued a recall for all batches of quetiapine oral suspension manufactured by Eaststone Limited due to an incorrect amount of the active ingredient, potentially leading to overdose. Approximately 166 bottles manufactured between October 2025 and January 2026 are affected. Patients are advised not to stop medication without consulting a healthcare professional.

MHRA Updates GLP-1 Guidance on Pancreatitis Risk

The MHRA has updated product information regarding the small risk of severe acute pancreatitis associated with GLP-1 medications. Healthcare professionals and patients are reminded to be alert to symptoms, and the MHRA is investigating genetic factors influencing this risk.

MHRA Updates Semaglutide Guidance on NAION Risk

The MHRA has updated its guidance for semaglutide prescribers and patients regarding the very rare risk of non-arteritic anterior ischemic optic neuropathy (NAION). The update alerts healthcare professionals and patients to the symptoms and advises immediate medical attention if vision changes occur. This guidance follows three reports of NAION associated with semaglutide since 2018.

FTC Sending $22.8 Million to Consumers for Deceptive Real Estate Schemes

The FTC is returning nearly $23 million to 1,659 consumers who were defrauded by deceptive real estate schemes, specifically Sanctuary Belize and Kanantik. This second distribution includes checks averaging $16,462 for Sanctuary Belize investors and $6,346.39 for Kanantik investors.

FTC Settlement with Express Scripts to Lower Drug Costs

The FTC has secured a settlement with Express Scripts, Inc. (ESI), a major pharmacy benefit manager, requiring significant changes to its business practices. These changes are projected to lower drug costs for patients by up to $7 billion over 10 years and increase revenue for community pharmacies.

FTC ANPRM on Rental Housing Fees Submitted to OMB

The FTC has submitted a draft Advance Notice of Proposed Rulemaking (ANPRM) concerning fees in the rental housing market to the Office of Management and Budget (OMB) for review. This action signals the agency's intent to potentially create new rules to address deceptive or unfair fees charged to renters.

FTC Draft Rulemaking on Negative Option Plans Submitted for Review

The FTC has submitted a draft Advance Notice of Proposed Rulemaking (ANPRM) concerning its Negative Option Rule to the Office of Management and Budget (OMB) for review. This action indicates the agency is considering potential revisions or new regulations related to negative option plans, which are common in subscription services.

FTC Warns 42 Law Firms on Anticompetitive DEI Hiring Practices

The FTC has issued warning letters to 42 law firms regarding potentially anticompetitive employment practices related to Diversity, Equity, and Inclusion (DEI) hiring. The firms, which participated in the Mansfield Certification program, are cautioned that coordinating on candidate pools or sharing pay information may violate antitrust laws.

ICO Enforcement Actions

The UK's Information Commissioner's Office (ICO) has published a list of its enforcement actions, including monetary penalties, prosecutions, and reprimands. This page serves as a central repository for these actions across various sectors.

ICO FOI Regulatory Actions

The Information Commissioner's Office (ICO) has updated its Freedom of Information (FOI) regulatory actions page. This update includes new notices, recommendations, and practice guidance related to FOI compliance for public authorities in the UK.

ICO Recovers Fines and Issues Penalties to DPP Law, 23andMe, Capita

The UK's Information Commissioner's Office (ICO) has recovered fines and issued penalties to several organisations, including DPP Law, 23andMe, and Capita. The ICO details its formal debt recovery actions, which can lead to insolvency proceedings and director disqualifications for non-payment of fines.

FDA Guidance on Promotional Labeling for Biosimilar Products

The FDA has issued new guidance addressing promotional labeling and advertising considerations for prescription reference products, biosimilar products, and interchangeable biosimilar products. The guidance aims to ensure promotional communications are accurate, truthful, and non-misleading for manufacturers and their representatives.

FDA Finalizes Guidance on Drug Dispute Resolution

The FDA has finalized guidance for industry on formal dispute resolution and administrative hearings for drugs subject to final administrative orders under section 505G of the FD&C Act. This guidance provides recommendations for resolving scientific and medical disputes between the Center for Drug Evaluation and Research (CDER) and drug sponsors.

FDA Draft Guidance on Bayesian Methodology in Drug Trials

The FDA has issued draft guidance on the use of Bayesian methodology in clinical trials for drug and biological products. This guidance is intended for sponsors and applicants and focuses on supporting primary inference for effectiveness and safety. The agency is seeking public comments on this draft document.

FDA Draft Guidance: Common Technical Document for Quality

The FDA has released draft guidance on the Common Technical Document (CTD) for the quality section of pharmaceutical registration applications. This guidance, developed under the International Council for Harmonisation (ICH), aims to harmonize the organization and presentation of quality data for human use pharmaceuticals. Comments on the draft are due by March 23, 2026.

FDA Draft Guidance on Patient Preference Studies

The FDA has released draft guidance on general considerations for patient preference studies, developed under the International Council for Harmonisation (ICH). The agency is accepting public comments on this draft guidance until April 7, 2026.

Gerard v. Cuevas - Unlawful Detainer Rent Case Opinion

This document is an opinion from a California court regarding an unlawful detainer rent case, Gerard v. Cuevas. It provides a judicial interpretation of relevant housing and landlord-tenant laws.

Esparza v. Superior Court Case Information

This notice provides case information for Esparza v. Superior Court, identified by case number E085807. The update is from the California Courts Appellate Cases system. No specific compliance actions or deadlines are detailed.

Bartholomew v. Parking Concepts, Inc. - Civil Litigation

This document pertains to the civil case Bartholomew v. Parking Concepts, Inc., case number A171546, filed in a US court. The filing represents a new addition to the court's docket, initiating legal proceedings between the named parties.

Antifa member arrested for cyberstalking, threatening ICE officers

Antifa member arrested for cyberstalking, threatening ICE officers

Florida man sentenced to 48 months for tax evasion

Florida man sentenced to 48 months for tax evasion

Defendant pleads guilty to international human and drug smuggling conspiracy

Defendant pleads guilty to international human and drug smuggling conspiracy

Justice Department resolves lawsuit against Pennsylvania borough zoning code

Justice Department resolves lawsuit against Pennsylvania borough zoning code

Florida man pleads guilty to biofuel fraud conspiracy

Florida man pleads guilty to biofuel fraud conspiracy

Engstrom v. United States - Sentencing Reversed

The Ninth Circuit Court of Appeals reversed the sentencing of Paul Engstrom in a drug case. The court found that the district court erred in its application of sentencing enhancements, requiring a resentencing. This decision impacts how certain drug offenses are sentenced within the Ninth Circuit.

Montejo-Gonzalez v. Bondi - Immigration Habeas Corpus

The Ninth Circuit Court of Appeals issued an opinion in Montejo-Gonzalez v. Bondi, addressing a habeas corpus petition related to immigration detention. The court's decision clarifies legal standards applicable to such cases.

People v. Gomez - Criminal Appeal

The California Court of Appeal has made available its opinion in the criminal case People v. Gomez, case number D086608. This update pertains to the availability of the court's decision in this specific appellate matter.